Medicalxreagentxpac
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE8EQ24D0005
- Awardee
-
Alfresa Corporation UEI J82GP59Q6LP6
- Awarding agency
-
Pacific Region
Troop Support, Department of Defense
- Task orders
- 40 $40,785 obligated
Award facts
- Opportunity
-
- Laboratory Reagent Requirements for NMRTC, Japan Solicitation · SPE8EQ24RQ008 · Posted Jun 26, 2024
- Combined order value
-
- $40,785 Current, with exercised options
- $782,933 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 95% used
- $42,839.25
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Alfresa Corporation, a Japan-based medical device and life sciences company, was awarded a single-award Indefinite Delivery Contract (IDC) by the Defense Logistics Agency (DLA) Troop Support Pacific on August 1, 2024, with a ceiling value of $42,839.25 and an ultimate completion date of September 30, 2025. This IDC supports the procurement of laboratory reagents and related medical supplies for U.S. Navy Medicine Readiness & Training Command (NMRTC) facilities throughout the Pacific region, specifically Naval Hospital Yokosuka and Branch Health Clinics located in Atsugi, Iwakuni, Sasebo, and Diego Garcia. The contract was established without set-aside designation following a solicitation posted June 26, 2024, indicating Alfresa Corporation's competitive positioning for open market procurements. The underlying requirement addresses critical in-vitro diagnostic substances essential for physician diagnosis and treatment of active duty personnel, family members, and eligible beneficiaries within the U.S. military medical system in the Pacific theater.
As of the data provided, 43 delivery orders have been issued under this IDC, with individual task order values ranging from zero dollars to $614,640.04, collectively demonstrating active utilization of the contract vehicle. The majority of delivery orders are for medical reagents and laboratory supplies with firm fixed-price structures and completion dates aligned with the IDC performance period. Performance locations remain in Japan for all documented task orders, consistent with the supporting military medical infrastructure in the region. Alfresa Corporation concurrently holds six active IDCs with the DLA Troop Support Pacific with combined ceiling values exceeding $1.4 million, establishing the contractor as a critical sole-source supplier of specialized medical products and preventive maintenance services for U.S. military medical operations in the Pacific region.
Task orders
Show all 40
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract SPE8EQ24D0005?
SPE8EQ24D0005 was awarded to Alfresa Corporation by Pacific Region (Troop Support) on August 1, 2024.
How much is contract SPE8EQ24D0005 worth?
Orders under SPE8EQ24D0005 have obligated $40,785. Their combined potential value, with all options, is $782,933. SPE8EQ24D0005's own ceiling is $42,839.
How many orders have been placed under contract SPE8EQ24D0005?
40 orders have been placed under SPE8EQ24D0005, the latest on September 8, 2025.
Who can order from contract SPE8EQ24D0005?
SPE8EQ24D0005 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE8EQ24D0005 competed?
The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV